Which treatment approach involves delivering a continuous subcutaneous insulin infusion using an insulin pump and providing bolus doses before meals to mimic physiologic insulin secretion?
Oral antidiabetic medication therapy.
Basal-bolus insulin therapy.
Sliding-scale insulin therapy.
Insulin glargine therapy.
The Correct Answer is B
Basal-bolus insulin therapy involves administering a continuous basal insulin infusion to provide background insulin coverage and delivering bolus doses of insulin before meals to cover postprandial glucose elevations.
Incorrect choices:
a. This choice is incorrect. Oral antidiabetic medications are not used in basal-bolus insulin therapy.
c. This choice is incorrect. Sliding-scale insulin therapy involves adjusting insulin doses based on current blood glucose levels, rather than providing consistent basal and mealtime coverage.
d. This choice is incorrect. Insulin glargine therapy provides long-acting basal insulin coverage but does not involve bolus doses before meals.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
Consuming a piece of fruit is an appropriate choice for treating hypoglycemia, as it provides a source of natural sugars that can help raise blood sugar levels.
Incorrect choices:
a. This choice is incorrect. A large serving of pasta contains complex carbohydrates that may take longer to raise blood sugar levels.
c. This choice is incorrect. A candy bar may provide a quick source of sugar, but it is often high in added sugars and unhealthy fats.
d. This choice is incorrect. Alcohol can further lower blood sugar levels and is not recommended for treating hypoglycemia.
Correct Answer is A
Explanation
Metformin is a commonly used oral antidiabetic medication that improves insulin sensitivity in peripheral tissues, reduces hepatic glucose production, and enhances glucose uptake by cells.
Incorrect choices:
b. This choice is incorrect. Glipizide is a sulfonylurea medication that stimulates insulin secretion from the pancreas, rather than increasing insulin sensitivity.
c. This choice is incorrect. Insulin lispro is a rapid-acting insulin analog used for mealtime coverage in insulin therapy.
d. This choice is incorrect. Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that stimulates insulin secretion and suppresses glucagon release, but it does not primarily target insulin sensitivity.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.